Line 1: |
Line 1: |
− | ==Myeloproliferative Neoplasms (MPN)== | + | ==Myeloproliferative Neoplasms (MPN) ([[Myeloproliferative Neoplasms (MPN)|Overview Page Link]])== |
| | | |
| *[[Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive]] | | *[[Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive]] |
Line 9: |
Line 9: |
| *[[Myeloproliferative Neoplasm (MPN), Unclassifiable]] | | *[[Myeloproliferative Neoplasm (MPN), Unclassifiable]] |
| | | |
− | ==Mastocytosis== | + | ==Mastocytosis ([[Mastocytosis|Overview Page Link]])== |
| | | |
| *[[Cutaneous Mastocytosis]] | | *[[Cutaneous Mastocytosis]] |
Line 15: |
Line 15: |
| *[[Mast Cell Sarcoma]] | | *[[Mast Cell Sarcoma]] |
| | | |
− | ==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2== | + | ==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 ([[Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2|Overview Page Link]])== |
| | | |
| *[[Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]] | | *[[Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]] |
Line 22: |
Line 22: |
| *[[Myeloid/Lymphoid Neoplasms with PCM1-JAK2]] | | *[[Myeloid/Lymphoid Neoplasms with PCM1-JAK2]] |
| | | |
− | ==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)== | + | ==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) ([[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)|Overview Page Link]])== |
| | | |
| *[[Chronic Myelomonocytic Leukemia (CMML)]] | | *[[Chronic Myelomonocytic Leukemia (CMML)]] |
Line 30: |
Line 30: |
| *[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]] | | *[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]] |
| | | |
− | ==Myelodysplastic Syndromes (MDS)== | + | ==Myelodysplastic Syndromes (MDS) ([[Myelodysplastic Syndromes (MDS)|Overview Page Link]])== |
| | | |
| *[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]] | | *[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]] |
Line 41: |
Line 41: |
| *[[Refractory Cytopenia of Childhood]] | | *[[Refractory Cytopenia of Childhood]] |
| | | |
− | ==Myeloid Neoplasms with Germline Predisposition== | + | ==Myeloid Neoplasms with Germline Predisposition ([[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== |
| | | |
| *[[Acute Myeloid Leukaemia with Germline CEBPA Mutation]] | | *[[Acute Myeloid Leukaemia with Germline CEBPA Mutation]] |
Line 50: |
Line 50: |
| *[[Myeloid Neoplasms with Germline GATA2 Mutation]] | | *[[Myeloid Neoplasms with Germline GATA2 Mutation]] |
| | | |
− | ==Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms== | + | ==Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms ([[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== |
| | | |
| *[[Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]] | | *[[Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]] |
Line 89: |
Line 89: |
| - [[Myeloid Leukemia Associated with Down Syndrome]] | | - [[Myeloid Leukemia Associated with Down Syndrome]] |
| | | |
− | ==Blastic Plasmacytoid Dendritic Cell Neoplasm== | + | ==Blastic Plasmacytoid Dendritic Cell Neoplasm ([[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== |
| | | |
| *[[Blastic Plasmacytoid Dendritic Cell Neoplasm]] | | *[[Blastic Plasmacytoid Dendritic Cell Neoplasm]] |
| | | |
− | ==Acute Leukemias of Ambiguous Lineage (MPAL)== | + | ==Acute Leukemias of Ambiguous Lineage (MPAL) ([[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Overview Page Link]])== |
| | | |
| *[[Acute Leukemias of Ambiguous Lineage]] | | *[[Acute Leukemias of Ambiguous Lineage]] |
Line 105: |
Line 105: |
| - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] | | - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]] |
| | | |
− | ==Precursor Lymphoid Neoplasms (B-ALL, T-ALL)== | + | ==Precursor Lymphoid Neoplasms (B-ALL, T-ALL) ([[Precursor Lymphoid Neoplasms|Overview Page Link]])== |
| | | |
| *[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]] | | *[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]] |
Line 125: |
Line 125: |
| - [[NK-Lymphoblastic Leukemia/Lymphoma]] | | - [[NK-Lymphoblastic Leukemia/Lymphoma]] |
| | | |
− | ==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas)== | + | ==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas) ([[Mature B-Cell Neoplasms|Overview Page Link]])== |
| | | |
| *[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]] | | *[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]] |
Line 235: |
Line 235: |
| *[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]] | | *[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]] |
| | | |
− | ==Mature T- and NK-cell Neoplasms== | + | ==Mature T- and NK-cell Neoplasms ([[Mature T- and NK-cell Neoplasms|Overview Page Link]])== |
| | | |
| *[[T-cell Prolymphocytic Leukemia]] | | *[[T-cell Prolymphocytic Leukemia]] |
Line 297: |
Line 297: |
| *[[Breast Implant-Associated Anaplastic Large Cell Lymphoma]] | | *[[Breast Implant-Associated Anaplastic Large Cell Lymphoma]] |
| | | |
− | ==Hodgkin Lymphomas== | + | ==Hodgkin Lymphomas ([[Hodgkin Lymphomas|Overview Page Link]])== |
| | | |
| *[[Nodular Lymphocyte Predominant Hodgkin Lymphoma]] | | *[[Nodular Lymphocyte Predominant Hodgkin Lymphoma]] |
Line 308: |
Line 308: |
| - [[Lymphocyte-Depleted Classic Hodgkin Lymphoma]] | | - [[Lymphocyte-Depleted Classic Hodgkin Lymphoma]] |
| | | |
− | ==Immunodeficiency-Associated Lymphoproliferative Disorders== | + | ==Immunodeficiency-Associated Lymphoproliferative Disorders ([[Immunodeficiency-Associated Lymphoproliferative Disorders|Overview Page Link]])== |
| | | |
| *[[Lymphomas Associated with HIV Infection]] | | *[[Lymphomas Associated with HIV Infection]] |
Line 323: |
Line 323: |
| *[[Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]] | | *[[Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]] |
| | | |
− | ==Histiocytic and Dendritic Cell Neoplasms== | + | ==Histiocytic and Dendritic Cell Neoplasms ([[Histiocytic and Dendritic Cell Neoplasms|Overview Page Link]])== |
| | | |
| *[[Histiocytic Sarcoma]] | | *[[Histiocytic Sarcoma]] |